Pharm 1 Flashcards
Bethanechol indications
treatment of post-op and postpartum urinary retention (nonobstructive)
Bethanechol MOA
a synthetic ester of choline, stimulates parasympathetic nervous system, increases bladder muscle tone, also stimulates gastric motility
Bethanechol side effects
hypotension, tachycardia, colic, headache, diaphoresis, cramps, diarrhea, salivation, vomiting, urinary urgency, lacrimation, miosis, bronchoconstriction
Bethanechol contraindications
mechanical obstruction of GI or GU, hyperthyroidism, peptic ulcers, asthma, CAD, hypotension, parkinsonism
Bethanechol drug interactions
ACE inhibitors may enhance effect, Beta blockers may enhance effect
Pilocarpine indications
Systematic: xerostomia
Ophthalmic: Glaucoma management
Pilocarpine MOA
cholinergic agonist, stimulates miosis and lowering of intraocular pressure
Pilocarpine side effects
lacrimation, diarrhea, nausea, vomiting, decreased visual acuity
Pilocarpine contraindications
anterior chamber inflammation
Pilocarpine drug interactions
ACE inhibitors may enhance effect, Beta blockers may enhance effect
Atropine indications
Sinus bradycardia, inhibition of salivation and secretions, antidote for anticholinesterase poisoning, mydriasis
Atropine MOA
blocks acetylcholine at parasympathetic, muscarinic receptors
Atropine side effects
tachycardia, palpitations, ataxia, disorientation, anhidrosis, constipation, xerostomia, urinary retention, angle-closure glaucoma, blurry vision, mydriasis, increased intraocular pressure, fever
Atropine contraindications
Narrow-angle glaucoma, pyloric stenosis, prostatic hypertrophy
Atropine drug interactions
Anticholinergics may enhance effect, ACE inhibitors may decrease effect, may enhance constipation and urinary retention with opiates
Scopolamine indications
treatment of nausea and vomiting, decrease salivary and respiratory secretions, produce amnesia, sedation and tranquilization
Scopolamine MOA
block acetylcholine at parasympathetic sites in smooth muscle, secretory glands, and CNS
Scopolamine side effects
orthostatic hypotension, tachycardia, restlessness and sedation (?), urinary retention, tremor, weakness, blurry vision
Scopolamine contraindications
glaucoma
Scopolamine drug interactions
Anticholinergics may enhance effect, ACE inhibitors may decrease effect, may enhance constipation and urinary retention with opiates
Ipratropium indications
bronchodilator
Ipratropium MOA
anticholinergic atropine derivative
Ipratropium side effects
bronchitis, sinusitis, xerostomia
Ipratropium contraindications
hypersensitivity
Ipratropium drug interactions
Anticholinergics may enhance effect, ACE inhibitors may decrease effect, may enhance constipation and urinary retention with opiates
Tubocurarine indications
skeletal muscle relaxation for operation
Tubocurarine MOA
nondepolarizing neuromuscular blocker, competitively block ACh
Tubocurarine side effects
hypotension
Tubocurarine contraindications
not commonly used, but one big contraindication is myocardial ischemia
Tubocurarine drug interactions
tetraethylammonium reverses effects
Succinylcholine indications
rapid sequence inductions, skeletal muscle relaxation for surgery
Succinylcholine MOA
the only depolarizing muscle relaxant in use today, activating nicotinic receptors to depolarize the neuromuscular junction
Succinylcholine side effects
arrhythmias, bradycardia, hyperkalemia, excessive salivation, increased intraocular pressure
Succinylcholine contraindications
malignant hyperthermia, acute phase of injury following multiple trauma or major burns, upper motor neuron lesion
Succinylcholine drug interactions
ACE inhibitors may increase serum concentration of succinylcholine, succinylcholine may enhance the bradycardic effect of opioids
botulinum toxin indications
induce local muscle paralysis, multiple applications
botulinum toxin MOA
blocks release of acetylcholine from synaptic vesicles
botulinum toxin side effects
pain, infection
botulinum toxin contraindications
infection at injection site, hypersensitivity
botulinum toxin drug interactions
aminoglycosides, neuromuscular blocking agents, anticholinergics all enhance effect
pyridostigmine indications
myasthenia gravis treatment, antagonism of nondepolarizing neuromuscular blockers, pretreatment for soman nerve gas exposure
pyridostigmine MOA
inhibition of acetylcholinesterase
pyridostigmine side effects
arrhythmias, convulsions, dizziness, diarrhea, nausea, salivation, vomiting, urinary urgency, lacrimation
pyridostigmine contraindications
asthma, bronchospasm, cholinergic sensitivity
pyridostigmine drug interactions
anticholinergic agents: diminished effect, beta blockers: enhanced, cholinergics: increased effect, succinylcholine: increased serum concentrations, nondepolarizing neuromuscular blockers: diminished effect
neostigmine indications
symptomatic control of myasthenia gravis, prevention of perioperative urinary retention, reversal of nondepolarizing neuromuscular blockers
neostigmine MOA
inhibition of acetylcholinesterase
neostigmine side effects
arrhythmias, convulsions, dizziness, diarrhea, nausea, salivation, vomiting, urinary urgency, lacrimation
neostigmine contraindications
peritonitis, urinary obstruction
neostigmine drug interactions
anticholinergic agents: diminished effect, beta blockers: enhanced, cholinergics: increased effect, succinylcholine: increased serum concentrations, nondepolarizing neuromuscular blockers: diminished effect
edrophonium indications
diagnosis of myasthenia gravis
edrophonium MOA
inhibition of acetylcholinesterase
edrophonium side effects
arrhythmias, convulsions, dizziness, diarrhea, nausea, salivation, vomiting, urinary urgency, lacrimation
edrophonium contraindications
hypersensitivity, GI or GU obstruction
edrophonium drug interactions
anticholinergic agents: diminished effect, beta blockers: enhanced, cholinergics: increased effect, succinylcholine: increased serum concentrations, nondepolarizing neuromuscular blockers: diminished effect
physostigmine indications
reversal of central nervous system anticholinergic syndrome
physostigmine MOA
inhibition of acetylcholinesterase, able to cross blood-brain barrier
physostigmine side effects
hallucinations, nervousness, restlessness, seizure, SLUD
physostigmine contraindications
GI, GU obstruction, asthma, diabetes, CV disease
phystostigmine drug interactions
anticholinergic agents: diminished effect, beta blockers: enhanced, cholinergics: increased effect, succinylcholine: increased serum concentrations, nondepolarizing neuromuscular blockers: diminished effect
epinephrine indications
treatment of anaphylactic reactions, treatment of shock hypotension, code drug for arrhythmia
epinephrine MOA
stimulates alpha and beta 1,2 adrenergic receptors
epinephrine side effects
angina, tachycardia, anxiety, xerostomia, urinary retention, tremor, weakness, exacerbation of glaucoma, diaphoresis
epinephrine contraindications
none in life-threatening situation, nose, ears, fingers, and toes for local anesthesia
epinephrine drug interactions
multiple, the gist: enhanced effect with sympathomimetics,
norepinephrine indications
severe hypotension
norepinephrine MOA
stimulates alpha and beta 1 adrenergic receptors, increasing heart contractility and vasoconstricting
norepinephrine side effects
arrhythmia, peripheral ischemia, anxiety, dyspnea
norepinephrine contraindications
hypersensitivity, non-emergent hypotension from extravasation
norepinephrine drug interactions
alpha and beta blockers, many others
dopamine indications
treatment of shock which persists after adequate fluid volume replacement
dopamine MOA
stimulates dopaminergic receptors and beta 1 adrenergic receptors
dopamine side effects
angina, anxiety, piloerection, elevated glucose, vomiting, increased intraocular pressure, polyuria, dyspnea
dopamine contraindications
hypersensitivity to sulfites, V fib
dopamine drug interactions
multiple, similar to norepi and epi
isoproterenol indications
mild or transient episodes of heart block
isoproterenol MOA
beta 1, 2 agonist
isoproterenol side effects
angina, dizziness, nausea, vomiting, tremor, blurry vision, diaphoresis
isoproterenol contraindications
angina, arrhythmia, cardiac glycoside intoxication
isoproterenol drug interactions
enhances sympathomimetics
albuterol indications
treatment or prevention of bronchospasm
albuterol MOA
beta 2 agonist in respiratory system
albuterol side effects
tachycardia, excitement, xerostomia, URI
albuterol contraindications
hypersensitivity, pregnancy (injected)
albuterol drug interactions
beta blockers diminish, sympathomimetics enhance
phenylephrine indications
nasal congestion
phenylephrine MOA
selective alpha agonist
phenylephrine side effects
burning, nasal discharge, sneezing
phenylephrine contraindications
hypersensitivity, V tach
phenylephrine drug interactions
alpha blockers diminish, sympathomimetics enhance
amphetamine indications
a drug of abuse, but some amphetamines are used to treat ADHD, obesity, and narcolepsy
amphetamine MOA
stimulates release of norepinephrine, serotonin, dopamine, inhibits monoamine oxidase
amphetamine side effects
arrhythmias, palpitations, agitation, anxiety, hallucinations, paranoia, restlessness, seizures, cool/blue fingers, bruxism, diaphoresis, liver failure, xerostomia
amphetamine contraindications
history of drug abuse, glaucoma, cardiovascular disease, hypertension, hyperthyroidism, agitation
amphetamine drug interactions
oodles, MAO inhibitors enhance, opioids enhanced, cns depressants less effective
levodopa indications (other name in combo)
treatment of parkinson’s (sinemet as levodopa/carbidopa)
levodopa MOA
blood-brain barrier crossing dopamine precursor
levodopa side effects
anorexia, nausea, tachycardia, hypotension, psychiatric problems
levodopa contraindications
hypersensitivity, narrow-angle glaucoma
levodopa drug interactions
oodles, MAOi’s enhanced, antipsychotics diminished, hypotensives enhanced
carbidopa indications
administered with levodopa to diminish side effects
carbidopa MOA
inhibits dopamine decarboxylase, does not cross blood brain barrier
carbidopa side effects
similar to levodopa, though less intense/frequent
carbidopa contraindications
hypersensitivity
carbidopa drug interactions
increases serum concentration of droxidopa, MAOi’s enhanced
entacapone indications
adjunct to levodopa/carbidopa for those with wearing off symptoms
entacapone MOA
inhibits catechol-0-methyltransferase, which converts levodopa into methyldopa. Methyldopa competes with levodopa
entacapone side effects
nausea, dyskinesa, dizziness, drowsiness